Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Fibrin Pad in Controlling Parenchymal Bleeding During Elective Hepatic Surgery
2010-019427-58Phase 3Completed
- Sponsor
- OMRIX Biopharmaceuticals, Inc.
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in spontaneous hepatic hemorrhage (SHH) comparing Fibrin Pad with Standard of Care (2 arms). Primary endpoint: Primary hemostasis endpoint. Started Mar 2010; status: completed.
02
Drugs
Fibrin Pad
03
Conditions
spontaneous hepatic hemorrhage (SHH)
Beyond the preview
Go deeper on 2010-019427-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019427-58.